Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.525 Right-to-Try Laws and Coverage of ServicesPayerPolicy · PREMERA-10-01-525-RIGHT-TO-TRY-LAWS-AND-COVERAGE-OF-SERVICES-5143A4BAFF | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.531 InterQual Criteria: Services Reviewed for Medical NecessityPayerPolicy · PREMERA-10-01-531-INTERQUAL-CRITERIA-SERVICES-REVIEWED-FOR-MEDICAL-N-52D1E8354E | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.527 Radiation Oncology: Services Reviewed by Carelon MedicalPayerPolicy · PREMERA-10-01-527-RADIATION-ONCOLOGY-SERVICES-REVIEWED-BY-CARELON-ME-7D5CB9824A | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 3.01.515 Behavioral Health: Residential/Sub-Acute WithdrawalPayerPolicy · PREMERA-3-01-515-BEHAVIORAL-HEALTH-RESIDENTIAL-SUB-ACUTE-WITHDRAWAL-A3A308A518 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.522 Routine Foot Care ServicesPayerPolicy · PREMERA-10-01-522-ROUTINE-FOOT-CARE-SERVICES-E552B9B4C9 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 9.03.507 Fundus PhotographyPayerPolicy · PREMERA-9-03-507-FUNDUS-PHOTOGRAPHY-66791AEB5C | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 3.01.522 Wilderness Therapy/Outdoor Behavioral Healthcare ResidentialPayerPolicy · PREMERA-3-01-522-WILDERNESS-THERAPY-OUTDOOR-BEHAVIORAL-HEALTHCARE-RE-96E6198655 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 1.01.527 Power Operated Vehicles (Scooters) (Excluding MotorizedPayerPolicy · PREMERA-1-01-527-POWER-OPERATED-VEHICLES-SCOOTERS-EXCLUDING-MOTORIZE-7AF2E2FB43 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 11.01.510 Skilled Nursing Facility (SNF): Admission, ContinuedPayerPolicy · PREMERA-11-01-510-SKILLED-NURSING-FACILITY-SNF-ADMISSION-CONTINUED-BFB81647B0 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 1.01.528 Hearing Aids (Excludes Implantable Devices)PayerPolicy · PREMERA-1-01-528-HEARING-AIDS-EXCLUDES-IMPLANTABLE-DEVICES-00DD2F3AD9 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.535 High-Risk Conditions (Oral Health) Dental BenefitPayerPolicy · PREMERA-10-01-535-HIGH-RISK-CONDITIONS-ORAL-HEALTH-DENTAL-BENEFIT-12503019A8 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.541 Medical Necessity Exception Criteria for Dispense asPayerPolicy · PREMERA-5-01-541-MEDICAL-NECESSITY-EXCEPTION-CRITERIA-FOR-DISPENSE-A-76A9F25971 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 1.01.526 Durable Medical Equipment Repair/ReplacementPayerPolicy · PREMERA-1-01-526-DURABLE-MEDICAL-EQUIPMENT-REPAIR-REPLACEMENT-3D455C2107 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.607 Continuity of Coverage for Maintenance MedicationsPayerPolicy · PREMERA-5-01-607-CONTINUITY-OF-COVERAGE-FOR-MAINTENANCE-MEDICATIONS-19BBB44B91 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.622 Exception Request to Utilization Management RestrictionsPayerPolicy · PREMERA-5-01-622-EXCEPTION-REQUEST-TO-UTILIZATION-MANAGEMENT-RESTRIC-9E77238E0D | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.542 Medical Necessity Criteria for Medication Safety: ControlledPayerPolicy · PREMERA-5-01-542-MEDICAL-NECESSITY-CRITERIA-FOR-MEDICATION-SAFETY-CO-0BE21D52D7 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 3.01.521 (effective October 9, 2026) Psychiatric and Other SpecifiedPayerPolicy · PREMERA-3-01-521-EFFECTIVE-OCTOBER-9-2026-PSYCHIATRIC-AND-OTHER-SPEC-3673C83D5D | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 1.01.519 Patient Lifts, Seat Lifts and Standing DevicesPayerPolicy · PREMERA-1-01-519-PATIENT-LIFTS-SEAT-LIFTS-AND-STANDING-DEVICES-62D793989B | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.546 Medical Necessity Criteria for Compounded MedicationsPayerPolicy · PREMERA-5-01-546-MEDICAL-NECESSITY-CRITERIA-FOR-COMPOUNDED-MEDICATIO-345EA3C2FE | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.051 Laboratory Testing for the Diagnosis of InflammatoryPayerPolicy · PREMERA-15-01-051-LABORATORY-TESTING-FOR-THE-DIAGNOSIS-OF-INFLAMMATO-EDA2D3F8B2 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.652 Miscellaneous Pharmacologic Treatments of PsoriasisPayerPolicy · PREMERA-5-01-652-MISCELLANEOUS-PHARMACOLOGIC-TREATMENTS-OF-PSORIASIS-0E8FEB40A8 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.650 Bispecific AntibodiesPayerPolicy · PREMERA-5-01-650-BISPECIFIC-ANTIBODIES-5A2951C2D7 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.050 Urinary Tumor Markers for Bladder CancerPayerPolicy · PREMERA-15-01-050-URINARY-TUMOR-MARKERS-FOR-BLADDER-CANCER-37944BE6EF | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.035 Immunopharmacologic Monitoring of Therapeutic SerumPayerPolicy · PREMERA-15-01-035-IMMUNOPHARMACOLOGIC-MONITORING-OF-THERAPEUTIC-SERU-32B165AF83 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.034 Biomarkers for Myocardial Infarction and Chronic HeartPayerPolicy · PREMERA-15-01-034-BIOMARKERS-FOR-MYOCARDIAL-INFARCTION-AND-CHRONIC-H-ECFE6F8E50 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.033 Epithelial Cell Cytology in Breast Cancer Risk AssessmentPayerPolicy · PREMERA-15-01-033-EPITHELIAL-CELL-CYTOLOGY-IN-BREAST-CANCER-RISK-ASS-72924955E3 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.025 Pancreatic Enzyme Testing for Acute PancreatitisPayerPolicy · PREMERA-15-01-025-PANCREATIC-ENZYME-TESTING-FOR-ACUTE-PANCREATITIS-9EF5200520 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.018 Diagnostic Testing of InfluenzaPayerPolicy · PREMERA-15-01-018-DIAGNOSTIC-TESTING-OF-INFLUENZA-76F6EC151C | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.015 Urine Culture Testing for BacteriaPayerPolicy · PREMERA-15-01-015-URINE-CULTURE-TESTING-FOR-BACTERIA-45E1A66ADA | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.011 Bone Turnover Markers TestingPayerPolicy · PREMERA-15-01-011-BONE-TURNOVER-MARKERS-TESTING-FB4786991E | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.010 Immune Cell Function AssayPayerPolicy · PREMERA-15-01-010-IMMUNE-CELL-FUNCTION-ASSAY-8CC9726347 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.007 Evaluation of Dry EyesPayerPolicy · PREMERA-15-01-007-EVALUATION-OF-DRY-EYES-692686A956 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 9.02.506 Dental RestorationsPayerPolicy · PREMERA-9-02-506-DENTAL-RESTORATIONS-1B0D9205DC | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.614 Erythroid Maturation AgentsPayerPolicy · PREMERA-5-01-614-ERYTHROID-MATURATION-AGENTS-AD5A4FF1A9 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 4.02.503 Infertility and Assisted Reproduction ServicesPayerPolicy · PREMERA-4-02-503-INFERTILITY-AND-ASSISTED-REPRODUCTION-SERVICES-9CE77C371D | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.052 Serum Biomarker Testing for Multiple Sclerosis andPayerPolicy · PREMERA-15-01-052-SERUM-BIOMARKER-TESTING-FOR-MULTIPLE-SCLEROSIS-AND-34719616AC | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.049 Testing of Homocysteine Metabolism-Related ConditionsPayerPolicy · PREMERA-15-01-049-TESTING-OF-HOMOCYSTEINE-METABOLISM-RELATED-CONDITI-9799A0D65A | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.047 Venous and Arterial Thrombosis Risk TestingPayerPolicy · PREMERA-15-01-047-VENOUS-AND-ARTERIAL-THROMBOSIS-RISK-TESTING-B5E75D636E | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.045 Prostate Biopsy Specimen AnalysisPayerPolicy · PREMERA-15-01-045-PROSTATE-BIOPSY-SPECIMEN-ANALYSIS-7928D231AC | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.044 Therapeutic Drug Monitoring for 5-FluorouracilPayerPolicy · PREMERA-15-01-044-THERAPEUTIC-DRUG-MONITORING-FOR-5-FLUOROURACIL-93E553278F | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.038 In Vitro Chemoresistance and Chemosensitivity AssaysPayerPolicy · PREMERA-15-01-038-IN-VITRO-CHEMORESISTANCE-AND-CHEMOSENSITIVITY-ASSA-7634F0F5A1 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.029 Vitamin B12 And Methylmalonic Acid TestingPayerPolicy · PREMERA-15-01-029-VITAMIN-B12-AND-METHYLMALONIC-ACID-TESTING-C67782B70E | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.027 Human Immunodeficiency Virus (HIV)PayerPolicy · PREMERA-15-01-027-HUMAN-IMMUNODEFICIENCY-VIRUS-HIV-8CB1279AF4 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.021 Gamma-glutamyl Transferase Testing in AdultsPayerPolicy · PREMERA-15-01-021-GAMMA-GLUTAMYL-TRANSFERASE-TESTING-IN-ADULTS-B2F4228DA7 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.012 Fecal Calprotectin Testing in AdultsPayerPolicy · PREMERA-15-01-012-FECAL-CALPROTECTIN-TESTING-IN-ADULTS-E9360EBC0A | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.006 Parathyroid Hormone, Phosphorus, Calcium, and MagnesiumPayerPolicy · PREMERA-15-01-006-PARATHYROID-HORMONE-PHOSPHORUS-CALCIUM-AND-MAGNESI-23400308BA | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.648 Insulin TherapyPayerPolicy · PREMERA-5-01-648-INSULIN-THERAPY-DD4B7C8B81 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.575 Dupixent (dupilumab)PayerPolicy · PREMERA-5-01-575-DUPIXENT-DUPILUMAB-58FA9FF647 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.048 Testing For Alpha-1 Antitrypsin DeficiencyPayerPolicy · PREMERA-15-01-048-TESTING-FOR-ALPHA-1-ANTITRYPSIN-DEFICIENCY-491B1EFF8F | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.043 Pathogen Panel TestingPayerPolicy · PREMERA-15-01-043-PATHOGEN-PANEL-TESTING-E83A4D1F93 | New policy |
|---|